Ad is loading...
Ad is loading...
ARANX vs FLMAX
ARANX vs FLMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ARANX vs. FLMAX commentary
Nov 18, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARANX is a StrongSell and FLMAX is a Buy.
FUNDAMENTALS
Fundamentals
ARANX has more cash in the bank: 1.35B vs. FLMAX (956M). FLMAX pays higher dividends than ARANX: FLMAX (1.72) vs ARANX (0.77). ARANX was incepted earlier than FLMAX: ARANX (10 years) vs FLMAX (8 years). FLMAX is a more actively managed with annual turnover of: 316.00 vs. ARANX (176.00). ARANX (2500) and FLMAX (2500) have matching initial minimum investment requirements. FLMAX (24.14) and ARANX (23.85) have marching annual gain over last year. FLMAX return over 5 years is better than : 44.86 vs. ARANX (29.78).
| ARANX | FLMAX | ARANX / FLMAX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 10 years | 8 years | - |
| Gain YTD | 14.702 | 18.694 | 79% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.35B | 956M | 141% |
| Annual Yield % from dividends | 0.77 | 1.72 | 45% |
| Returns for 1 year | 23.85 | 24.14 | 99% |
| Returns for 3 years | 0.53 | 13.55 | 4% |
| Returns for 5 years | 29.78 | 44.86 | 66% |
| Returns for 10 years | 39.47 | N/A | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| INDS | 38.51 | 0.14 | +0.36% |
| Pacer Benchmark Industrial RE SCTR ETF | |||
| PBTP | 25.42 | 0.03 | +0.10% |
| Invesco 0-5 Yr US TIPS ETF | |||
| LMBS | 48.64 | -0.03 | -0.06% |
| First Trust Low Duration Oppos ETF | |||
| PPH | 86.59 | -1.58 | -1.79% |
| VanEck Pharmaceutical ETF | |||
| HELX | 28.55 | -1.41 | -4.72% |
| Franklin Genomic Advancements ETF | |||